ZIMMER BIOMET HOLDINGS, INC. - Common Stock (ZBH) Institutional Ownership

13F Institutional Holders and Ownership History from Q1 2014 to Q4 2025

Type / Class
Equity / Common Stock
Symbol
ZBH on NYSE
Shares outstanding
197,298,777
Price per share
$89.92
All holders as of 30 Sep 2025
Q3 2025
Total 13F shares
191,162,745
Total reported value
$18,829,760,296
% of total 13F portfolios
0.01%
Share change
-791,233
Value change
-$51,377,456
Number of holders
951
Price from insider filings
$89.92
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Significant Owners of ZIMMER BIOMET HOLDINGS, INC. - Common Stock (ZBH) based on Schedule 13D/G filings

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
DODGE & COX 11% +10% $2,103,678,478 +$191,384,844 22,097,463 +10% Dodge & Cox 30 Jun 2025
BlackRock, Inc. 7.8% $1,580,678,480 15,573,187 BlackRock, Inc. 31 Mar 2025

As of 30 Sep 2025, 951 institutional investors reported holding 191,162,745 shares of ZIMMER BIOMET HOLDINGS, INC. - Common Stock (ZBH). This represents 97% of the company’s total 197,298,777 outstanding shares.

Top 25 Institutional Shareholders

The largest institutional shareholders of ZIMMER BIOMET HOLDINGS, INC. - Common Stock (ZBH) together control 74% of the company’s outstanding shares — a level of ownership often associated with strong institutional conviction and long‑term capital commitment.

Institution Ownership % Shares Held Share Change % Portfolio % Holdings Value
VANGUARD GROUP INC 12% 23,291,224 +0.17% 0.03% $2,294,185,565
Dodge & Cox 12% 23,216,173 +5.1% 1.2% $2,286,793,041
BlackRock, Inc. 8.2% 16,149,859 +0.21% 0.03% $1,590,761,196
PRICE T ROWE ASSOCIATES INC /MD/ 7.6% 15,082,438 +1.9% 0.16% $1,485,621,000
STATE STREET CORP 4.4% 8,631,760 -1.3% 0.03% $852,260,365
Capital International Investors 3.8% 7,550,754 +11% 0.12% $743,749,269
GEODE CAPITAL MANAGEMENT, LLC 2.6% 5,197,223 +1.4% 0.03% $509,869,393
AMERICAN CENTURY COMPANIES INC 2.6% 5,176,696 -9.3% 0.26% $509,904,828
HARRIS ASSOCIATES L P 2.4% 4,750,567 +27% 0.75% $467,930,836
FRANKLIN RESOURCES INC 2.4% 4,668,130 -0.12% 0.12% $459,810,810
PRIMECAP MANAGEMENT CO/CA/ 2.2% 4,250,630 -9.8% 0.32% $418,687,055
AMERIPRISE FINANCIAL INC 1.9% 3,789,200 +1.6% 0.09% $373,239,165
VAN ECK ASSOCIATES CORP 1.8% 3,476,906 +2.4% 0.32% $342,475,000
Invesco Ltd. 1.5% 3,038,386 -34% 0.05% $299,281,025
DIMENSIONAL FUND ADVISORS LP 1.2% 2,269,122 +1.8% 0.05% $223,503,349
NORTHERN TRUST CORP 1.1% 2,109,159 -3.5% 0.03% $207,752,164
VICTORY CAPITAL MANAGEMENT INC 0.98% 1,924,763 +25% 0.13% $198,617,499
MORGAN STANLEY 0.86% 1,693,307 -7.9% 0.01% $166,791,020
HOTCHKIS & WILEY CAPITAL MANAGEMENT LLC 0.82% 1,610,361 -1.2% 0.49% $158,620,559
Legal & General Group Plc 0.76% 1,508,797 +1.1% 0.03% $148,616,511
UBS AM, A DISTINCT BUSINESS UNIT OF UBS ASSET MANAGEMENT AMERICAS LLC 0.76% 1,499,156 -18% 0.03% $147,666,868
EQUITY INVESTMENT CORP 0.73% 1,441,955 -0.77% 3% $142,032,544
ROYAL BANK OF CANADA 0.71% 1,406,087 +37% 0.02% $138,500,000
Bank of New York Mellon Corp 0.71% 1,397,375 -2.3% 0.02% $137,641,402
BANK OF AMERICA CORP /DE/ 0.68% 1,332,954 +5.9% 0.01% $131,295,966

Institutional Holders of ZIMMER BIOMET HOLDINGS, INC. - Common Stock (ZBH) across Reporting Periods

Period Reported Shares, Excl. Options Value, Excl. Options Value Change Price (Median) Investors
2025 Q4 2,502,612 $225,496,506 +$228,539 $89.92 143
2025 Q3 191,162,745 $18,829,760,296 -$51,377,456 $98.50 951
2025 Q2 192,626,878 $17,571,714,234 +$792,544,334 $91.21 924
2025 Q1 182,679,026 $20,673,195,452 +$78,572,106 $113.18 989
2024 Q4 182,046,192 $19,223,206,496 -$24,425,238 $105.63 1,016
2024 Q3 180,798,566 $19,495,146,884 -$518,996,441 $107.95 970
2024 Q2 185,767,292 $20,157,286,081 +$84,265,168 $108.53 993
2024 Q1 184,944,590 $24,386,333,122 +$378,599,102 $131.98 1,001
2023 Q4 182,158,658 $22,167,115,854 -$108,284,800 $121.70 1,024
2023 Q3 183,160,339 $20,544,194,913 -$330,363,038 $112.22 1,007
2023 Q2 184,990,423 $26,912,517,176 +$79,651,340 $145.60 1,024
2023 Q1 184,640,260 $23,852,215,294 -$197,494,318 $129.20 983
2022 Q4 186,466,854 $23,771,585,025 +$15,032,266 $127.50 966
2022 Q3 187,764,427 $19,641,670,250 -$40,775,687 $104.55 902
2022 Q2 187,706,817 $19,721,444,102 -$182,677,512 $105.06 935
2022 Q1 190,563,833 $24,370,218,008 +$507,478,442 $127.90 950
2021 Q4 186,413,133 $23,689,681,090 -$291,970,620 $127.04 970
2021 Q3 186,211,587 $27,266,031,241 -$194,909,437 $146.36 964
2021 Q2 187,061,496 $30,082,557,789 +$495,687,147 $160.82 1,001
2021 Q1 186,359,556 $29,840,024,809 +$371,366,968 $160.08 1,009
2020 Q4 184,159,282 $28,376,620,252 +$233,718,901 $154.09 992
2020 Q3 183,057,491 $24,891,885,860 -$292,751,827 $136.14 915
2020 Q2 185,173,110 $22,106,459,840 +$349,158,071 $119.36 931
2020 Q1 182,976,068 $18,484,142,744 -$128,563,361 $101.08 867
2019 Q4 182,320,213 $27,288,420,127 +$122,625,292 $149.68 970
2019 Q3 181,638,610 $24,924,990,806 +$52,955,829 $137.27 881
2019 Q2 181,338,229 $21,328,691,960 +$509,312,105 $117.74 869
2019 Q1 183,141,948 $23,385,773,159 -$2,465,400 $127.70 883
2018 Q4 183,562,739 $19,042,594,576 +$133,152,083 $103.72 858
2018 Q3 181,206,133 $23,817,026,631 +$320,924,723 $131.47 879
2018 Q2 179,046,031 $19,952,228,634 -$45,838,188 $111.44 862
2018 Q1 179,585,994 $19,581,945,611 +$365,957,546 $109.04 870
2017 Q4 175,771,522 $21,208,047,550 +$25,400,388 $120.67 861
2017 Q3 175,700,291 $20,565,725,169 +$55,115,976 $117.09 812
2017 Q2 175,212,356 $22,491,948,552 +$517,719,217 $128.40 811
2017 Q1 171,720,220 $20,952,474,267 +$1,903,680,066 $122.11 812
2016 Q4 172,466,891 $17,802,532,582 -$347,736,787 $103.20 803
2016 Q3 174,983,173 $22,734,934,107 -$479,447,636 $130.02 802
2016 Q2 179,297,112 $21,585,892,267 +$250,552,456 $120.38 760
2016 Q1 177,344,357 $18,908,137,506 -$7,485,897,888 $106.63 733
2015 Q4 248,713,876 $25,514,834,478 +$90,571,968 $102.59 731
2015 Q3 248,025,139 $23,296,218,192 +$307,629,347 $93.93 715
2015 Q2 244,694,506 $26,728,017,386 +$10,644,232,477 $109.23 741
2015 Q1 147,185,443 $17,294,751,097 +$234,369,375 $117.52 755
2014 Q4 145,003,276 $16,448,197,642 +$78,405,584 $113.42 742
2014 Q3 144,225,600 $14,502,525,028 +$149,512,861 $100.55 713
2014 Q2 142,207,768 $14,768,375,192 +$131,559,723 $103.86 699
2014 Q1 141,339,897 $13,368,781,410 -$316,398,959 $94.58 694